Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001)

類似資料

• Ductal carcinoma in situ arising in tubular adenoma of the breast
  著者:: Saimura, Michiyo, 等
  出版事項: (2012)
• Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy
  著者:: HAYASHI, MITSUHIRO, 等
  出版事項: (2011)
• PTEN-deficient cancers depend on PIK3CB
  著者:: Wee, Susan, 等
  出版事項: (2008)
• An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer.
  著者:: Aiko Sueta, 等
  出版事項: (2014-01-01)
• An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
  著者:: Sueta, Aiko, 等
  出版事項: (2014)